Sponsors (7)
The bill seeks to improve emergency allergic-reaction outcomes by enabling and tracking epinephrine use by first responders and educating the public, but its benefits depend on future funding and raise fiscal, administrative, privacy, and messaging risks that could limit or complicate implementation.
People who experience severe allergic reactions (children, families, people in urban and rural communities) are more likely to get faster recognition and timely epinephrine treatment because the bill promotes public education and clarifies that first responders can administer epinephrine, which can reduce fatalities and severe outcomes.
Law enforcement agencies could obtain emergency epinephrine through grant authority so officers can carry and administer it in the field, increasing access to life-saving treatment before EMS arrival.
Required annual public reporting on officer administrations of epinephrine will give law enforcement, local and state governments, and the public data to identify training and equipment gaps, improve emergency planning, and increase oversight and accountability.
Law enforcement and local governments get no immediate, guaranteed benefit because the bill does not specify funding, grant eligibility, or implementation details—leaving outcomes dependent on future appropriations or rules.
If grants and the public-education campaign are funded, taxpayers will bear additional federal costs for purchasing epinephrine and running the campaign, with no offsets specified.
Collecting and reporting epinephrine-administration data will create administrative and compliance costs for agencies—potentially diverting limited resources and disproportionately burdening smaller and tribal agencies with new tracking requirements.
Based on analysis of 4 sections of legislative text.
Creates a grant program to improve law enforcement access to epinephrine, requires annual reporting on officer epinephrine use, and mandates a public awareness campaign within 180 days.
Introduced June 17, 2025 by Laura Gillen · Last progress June 17, 2025
Creates a federal program to improve law enforcement access to emergency epinephrine, requires annual federal reporting on how often officers administer epinephrine products, and directs a joint public awareness campaign about anaphylaxis and the role of officers and first responders in using epinephrine. The bill sets a 180‑day deadline for launching the public campaign but does not include specific funding levels or operational details for the new grant program in the text provided.